Feasibility and safety of left bundle branch area pacing in cardiac amyloidosis. A single center experience
© 2023 Wiley Periodicals LLC..
BACKGROUND: Conventional right ventricle (RV) pacemaker stimulation has been associated with worse clinical outcomes in patients with cardiac amyloidosis (CA). Left bundle branch area pacing (LABPP) has been suggested as a promising alternative. We sought to assess the safety, feasibility, and outcomes of LABPP in patients with CA.
METHODS: We retrospectively analyzed echocardiography and pacing parameters and clinical outcomes in 23 consecutive patients with CA and LBBAP implanted from June 2020 to October 2022.
RESULTS: LBBAP was successfully performed in 22 over 23 patients (19 male, 78.6 ± 11.7 years, 20 ATTR, mean LVEF 45.5 ± 16.2%). After the procedure, 9 patients showed Qr pattern and 11 a qR pattern in V1 on ECG. Average procedure time was 67 ± 28 min. After 7.7 ± 5.2 months follow-up, no procedure-related complications had occurred. Although, a significant reduction in QRS width (p = .001) was achieved, we did not observe significant changes in LVEF and Nt ProBNP at 6 months of follow-up. Pacing parameters were stable during follow-up: LBB capture threshold and R wave amplitude were 1.0 ± 0.5 V and 10.6 ± 6.0 mV versus 0.8 ± 0.1 V, p = .21 and 10.6 ± 5.1 mV (p = .985) at follow up.
CONCLUSION: LBBAP is safe and feasible pacing technique for patients with CA. LBBAP is associated with significant narrowing of QRSd without worsening in LVEF and Nt-proBNP.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
---|---|
Enthalten in: |
Pacing and clinical electrophysiology : PACE - 47(2024), 1 vom: 01. Jan., Seite 149-155 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pham-Trung, Chinh [VerfasserIn] |
---|
Links: |
---|
Themen: |
AL amyloidosis |
---|
Anmerkungen: |
Date Completed 11.01.2024 Date Revised 19.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/pace.14894 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365465240 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365465240 | ||
003 | DE-627 | ||
005 | 20240320233736.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/pace.14894 |2 doi | |
028 | 5 | 2 | |a pubmed24n1337.xml |
035 | |a (DE-627)NLM365465240 | ||
035 | |a (NLM)38055612 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pham-Trung, Chinh |e verfasserin |4 aut | |
245 | 1 | 0 | |a Feasibility and safety of left bundle branch area pacing in cardiac amyloidosis. A single center experience |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.01.2024 | ||
500 | |a Date Revised 19.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 Wiley Periodicals LLC. | ||
520 | |a BACKGROUND: Conventional right ventricle (RV) pacemaker stimulation has been associated with worse clinical outcomes in patients with cardiac amyloidosis (CA). Left bundle branch area pacing (LABPP) has been suggested as a promising alternative. We sought to assess the safety, feasibility, and outcomes of LABPP in patients with CA | ||
520 | |a METHODS: We retrospectively analyzed echocardiography and pacing parameters and clinical outcomes in 23 consecutive patients with CA and LBBAP implanted from June 2020 to October 2022 | ||
520 | |a RESULTS: LBBAP was successfully performed in 22 over 23 patients (19 male, 78.6 ± 11.7 years, 20 ATTR, mean LVEF 45.5 ± 16.2%). After the procedure, 9 patients showed Qr pattern and 11 a qR pattern in V1 on ECG. Average procedure time was 67 ± 28 min. After 7.7 ± 5.2 months follow-up, no procedure-related complications had occurred. Although, a significant reduction in QRS width (p = .001) was achieved, we did not observe significant changes in LVEF and Nt ProBNP at 6 months of follow-up. Pacing parameters were stable during follow-up: LBB capture threshold and R wave amplitude were 1.0 ± 0.5 V and 10.6 ± 6.0 mV versus 0.8 ± 0.1 V, p = .21 and 10.6 ± 5.1 mV (p = .985) at follow up | ||
520 | |a CONCLUSION: LBBAP is safe and feasible pacing technique for patients with CA. LBBAP is associated with significant narrowing of QRSd without worsening in LVEF and Nt-proBNP | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a AL amyloidosis | |
650 | 4 | |a cardiac amyloidosis | |
650 | 4 | |a cardiac resynchronization therapy | |
650 | 4 | |a heart failure | |
650 | 4 | |a left bundle branch area pacing | |
650 | 4 | |a transthyretin cardiac amyloidosis | |
700 | 1 | |a Veloza-Urrea, Darwin |e verfasserin |4 aut | |
700 | 1 | |a Segura-Domínguez, Melodie |e verfasserin |4 aut | |
700 | 1 | |a De la Rosa Rojas, Yuleisy |e verfasserin |4 aut | |
700 | 1 | |a Aguilera-Agudo, Cristina |e verfasserin |4 aut | |
700 | 1 | |a García-Izquierdo, Eusebio Alejandro |e verfasserin |4 aut | |
700 | 1 | |a García-Rodríguez, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Jiménez-Sánchez, Diego |e verfasserin |4 aut | |
700 | 1 | |a Lorente-Ros, Alvaro |e verfasserin |4 aut | |
700 | 1 | |a Mingo-Santos, Susana |e verfasserin |4 aut | |
700 | 1 | |a Gonzalez-Lopez, Esther |e verfasserin |4 aut | |
700 | 1 | |a Domínguez, Fernando |e verfasserin |4 aut | |
700 | 1 | |a Garcia-Pavia, Pablo |e verfasserin |4 aut | |
700 | 1 | |a Toquero-Ramos, Jorge |e verfasserin |4 aut | |
700 | 1 | |a Fernández-Lozano, Ignacio |e verfasserin |4 aut | |
700 | 1 | |a Castro-Urda, Víctor |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pacing and clinical electrophysiology : PACE |d 1983 |g 47(2024), 1 vom: 01. Jan., Seite 149-155 |w (DE-627)NLM000837431 |x 1540-8159 |7 nnns |
773 | 1 | 8 | |g volume:47 |g year:2024 |g number:1 |g day:01 |g month:01 |g pages:149-155 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/pace.14894 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 47 |j 2024 |e 1 |b 01 |c 01 |h 149-155 |